RABINOWITS, G.; HOMSI, J.; NIKANJAM, M.; GENTRY, R.; STRASSWIMMER, J.; VENNA, S.; MIGDEN, M.; CHANDRA, S.; RUIZ, E.; ZHANG, H.; MCGINNISS, J.; SELUZHYTSKY, A.; DESAI, J. Demographics, Prior Therapies, and Reasons for Cemiplimab Treatment: Prospective CemiplimAb-rwlc Survivorship and Epidemiology (C.A.S.E.) Study in Patients with Advanced Cutaneous Squamous Cell Carcinoma. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 6, p. s125, 2020. DOI: 10.25251/skin.4.supp.125. Disponível em: https://jofskin.org/index.php/skin/article/view/1098. Acesso em: 15 jul. 2024.